Tirzepatide 20mg (R&D Only)

Name: Tirzepatide 20mg (R&D Only)
Price: 85.00 GBP
Availability: InStock

£85.00

4–6 week supply

‍A 20mg Tirzepatide formulation supplied in a pre-filled research device, provided exclusively for controlled laboratory R&D applications. Delivered in sealed format to support compound stability analysis, formulation studies, and delivery mechanism evaluation.

‍Produced for laboratory research only. Not for human or veterinary consumption.

Each Tirzepatide 20mg Research kit includes:
Pre-filled Research pen (20mg Tirzepatide)
Research information sheet

‍Storage:
Store refrigerated (2–8°C). Do not freeze.
Supplied in fixed-volume sealed format for laboratory analysis.

‍Delivery: Dispatched with a cold pack.
Tracked 2 DAY UK Delivery.

‍Research & Development purposes only

Category: Retatrutide Tag: Tirzepatide 20mg (R&D Only)

Description
Reviews (0)

Tirzepatide 20mg (R&D Only)

Tirzepatide is an investigational medication currently being researched for its potential applications in managing type 2 diabetes and obesity. The designation “R&D Only” indicates that this formulation is intended solely for research and development purposes and is not yet approved for general medical use.

Key Information

Dosage: Each vial contains 20mg of Tirzepatide.
Research Use: This product is specifically for research and development purposes and should only be used in approved clinical trials.

Potential Uses

Type 2 Diabetes Management: Tirzepatide is being studied for its efficacy in lowering blood sugar levels and improving glycemic control in patients with type 2 diabetes.
Weight Loss: It may also have applications in promoting weight loss for individuals with obesity or those at risk of developing metabolic syndrome.

Mechanism of Action

Tirzepatide mimics the effects of two incretin hormones, GLP-1 (glucagon-like peptide-1) and GIP (gastric inhibitory polypeptide), which play a significant role in:

Enhancing Insulin Secretion: Stimulating the pancreas to release insulin in response to meals.
Reducing Glucagon Levels: Lowering glucose production by the liver.
Slowing Gastric Emptying: Helping to increase feelings of fullness and reduce appetite.

Important Considerations

Clinical Trials Only: Since this formulation is for research purposes, it should not be administered outside of a controlled research environment.
Supervision Required: Any use of investigational drugs should be conducted under the supervision of qualified healthcare professionals in compliance with regulatory guidelines.

Conclusion

The Tirzepatide 20mg (R&D Only) formulation is designed for research purposes to explore its potential benefits in treating type 2 diabetes and aiding in weight management. It is essential to conduct any research involving this drug within approved clinical trials and under appropriate supervision.